Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2011 3
2012 2
2013 2
2014 3
2015 4
2016 1
2017 1
2018 1
2020 2
2021 1
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Cannon CP, et al. N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3. N Engl J Med. 2015. PMID: 26039521 Free article. Clinical Trial.
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Kang-Ai Injection Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway.
Zheng CL, Hou KZ, Wang AQ, Fang WX, Yu ST, Liang JE, Qi HY, Qu XJ, Liu YP, Che XF. Zheng CL, et al. Chin J Integr Med. 2022 Jun;28(6):524-530. doi: 10.1007/s11655-020-3265-6. Epub 2020 Jul 9. Chin J Integr Med. 2022. PMID: 32648126
OBJECTIVE: To explore the mechanisms underlying the proliferative inhibition of Chinese herbal medicine Kang-Ai injection (KAI) in gastric cancer cells. METHODS: Gastric cancer cell lines MGC803 and BGC823 were treated by 0, 0.3%, 1%, 3% and 10% KAI for 24, 48 and 7 …
OBJECTIVE: To explore the mechanisms underlying the proliferative inhibition of Chinese herbal medicine Kang-Ai injection (KAI) in ga …
Anti-oxidant and anti-inflammatory effects of ellagic and punicic acid in an in vitro model of cardiac fibrosis.
Mannino F, Imbesi C, Bitto A, Minutoli L, Squadrito F, D'Angelo T, Booz C, Pallio G, Irrera N. Mannino F, et al. Biomed Pharmacother. 2023 Jun;162:114666. doi: 10.1016/j.biopha.2023.114666. Epub 2023 Apr 6. Biomed Pharmacother. 2023. PMID: 37030134 Free article.
Immortalized Human Cardiac Fibroblasts (IM-HCF) were stimulated with 10 ng/ml of TGF-beta1 for 24 h to induce a fibrotic damage. Cells were then treated with EA (1 M), PA (1 M) or EA+PA for additional 24 h. ...
Immortalized Human Cardiac Fibroblasts (IM-HCF) were stimulated with 10 ng/ml of TGF-beta1 for 24 h to induce a fibrotic damage. Cell …
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2024 May;14(4_suppl):690S-714S. doi: 10.1177/21925682241245615. Global Spine J. 2024. PMID: 38726630 Free PMC article. No abstract available.
Actinidin reduces gluten-derived immunogenic peptides reaching the small intestine in an in vitro semi-dynamic gastrointestinal tract digestion model.
Jayawardana IA, Boland MJ, Loo TS, McNabb WC, Montoya CA. Jayawardana IA, et al. Food Res Int. 2022 Sep;159:111560. doi: 10.1016/j.foodres.2022.111560. Epub 2022 Jun 24. Food Res Int. 2022. PMID: 35940780
The rate of increase of DH of gluten and the amount of R5 epitopes present in the small intestine during the first 30 min of GIT digestion with actinidin was 0.3%/min and 4.8 ng/g of gluten respectively, whereas it was 0.01%/min and 60.9 ng/g of gluten respectively …
The rate of increase of DH of gluten and the amount of R5 epitopes present in the small intestine during the first 30 min of GIT digestion w …
Extraction of Treatment Information From Electronic Health Records and Evaluation of Testosterone Recovery in Patients With Prostate Cancer.
Guin S, Jun T, Patel VG, Ayers KL, Deitz M, Cai Y, Zhou X, Tsao CK, Oh WK, Chen R, Liaw BC. Guin S, et al. JCO Clin Cancer Inform. 2022 Jun;6:e2200010. doi: 10.1200/CCI.22.00010. JCO Clin Cancer Inform. 2022. PMID: 35696627 Free PMC article.

Baseline testosterone was the strongest predictor of T-recovery in these patients. Patients with a baseline testosterone 300 ng/dL recovered in 9.79 versus 38 months for patients with baseline testosterone < 300 ng/dL (P < .0001). Shorter prostate-specific ant

…
Baseline testosterone was the strongest predictor of T-recovery in these patients. Patients with a baseline testosterone 300 ng/dL re …
Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer.
Liaw BC, Tsao CK, Seng S, Jun T, Gong Y, Galsky MD, Oh WK. Liaw BC, et al. Oncologist. 2023 Apr 6;28(4):366-e224. doi: 10.1093/oncolo/oyac224. Oncologist. 2023. PMID: 36519763 Free PMC article. Clinical Trial.
RESULTS: Thirteen docetaxel-refractory mCRPC patients were enrolled, with a median age of 69 years (range 54-77 years) and median PSA of 71.7 ng/mL (range 0.04-3057). Four of 13 patients (31%) responded to satraplatin (defined as a PSA decline of 30%). ...
RESULTS: Thirteen docetaxel-refractory mCRPC patients were enrolled, with a median age of 69 years (range 54-77 years) and median PSA of 71. …
31 results